Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-controlled, Double -Blind Randomised Trial of Suvorexant in the Management Comorbid Sleep Disorder and Alcohol Dependence

NCT03897062 is registered in ClinicalTrials.gov with The Florey Institute of Neuroscience and Mental Health as lead sponsor.

NCT NCT03897062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03897062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-controlled, Double -Blind Randomised Trial of Suvorexant in the Management Comorbid Sleep Disorder and Alcohol Dependence
Lead sponsor
The Florey Institute of Neuroscience and Mental Health
Phase
Phase 2
Overall status
Terminated
Start date
August 26, 2019
Completion date
July 31, 2022
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, insomnia